目的:观察苗药金乌健骨汤治疗类风湿关节炎的临床疗效。方法:选择确诊的类风湿关节炎患者60例,在服用甲氨喋呤(MTX)和来氟米特的基础上,采用随机分组法,分为观察组30例,予服用苗药金乌健骨汤;对照组30例,予口服白芍总苷胶囊;观察患者临床症状、体征及炎性活动指标等改善情况,并在3个月后评价疗效。结果:观察组临床控显率(67.86%)、总有效率(85.71%)、不良反应发生率(13.33%),与对照组临床控显率(37.04%)、总有效率(51.85%)、不良反应发生率(30.00%),两组比较差异有统计学意义(P〈0.05或P〈0.01);观察组在减轻关节肿胀、疼痛,改善关节功能,降低炎性活动指标等方面均优于对照组(P〈0.05或P〈0.01)。结论:苗药金乌健骨汤治疗类风湿关节炎有良好疗效,表现在控制类风湿关节炎患者病情、实验室炎症指标及减少不良反应等方面,且效果优于白芍总苷胶囊,值得在临床上进一步推广。
Objective:To observe the clinical efficacy of the Miao Nationality Medicine Jinwujiangu decoction in the treatment of rheumatoid arthritis. Methods: 60 cases patients of rheumatoid arthritis were e- qually randomized into treatment group and control group. On the basis treatment of Methotrexate (MTX) and Leflunomide Tablets,the treatment group received the Miao Nationality Medicine Jinwujiangu decoction, and the control group received the Total Glucosides of Paeony Capsules. Results: The clinical cure rate of the treat- ment group was 67.86% ,the total effective rate was 85.71%, the adverse reaction rate wasl3.33% ;and the clinical cure rate of the control group was37.04% ,the total effective rate was 51.85% ,the adverse reaction rate was30.00%. Two groups were statistical significance ( P 〈 0.05 orP 〈 0.01 ). The efficacy as reducing joint swelling and pain,improving joint functions ,reducing laboratory parameters, which of treatment group was better than that of control group( P 〈 0.05 orP 〈 0.01 ). Conclusions : The Miao Nationality Medicine Jinwu- jiangu decoction has a good curative effect in treating rheumatoid arthritis, which can be seen in controlling the rheumatoid arthritis patients'disease and laboratory parameters, reducing adverse reactions, etc. And the clinical efficacy of the Miao Nationality Medicine Jinwujiangu decoction is better than that of the Total Glueo- sides of Paeony Capsules.